Mexico Blood Transfusion Diagnostics Market Size & Outlook
Related Markets
Mexico blood transfusion diagnostics market highlights
- The Mexico blood transfusion diagnostics market generated a revenue of USD 60.8 million in 2020 and is expected to reach USD 104.9 million by 2027.
- The Mexico market is expected to grow at a CAGR of 8.1% from 2021 to 2027.
- In terms of segment, reagents & kits was the largest revenue generating product in 2020.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Blood transfusion diagnostics market data book summary
| Market revenue in 2020 | USD 60.8 million |
| Market revenue in 2027 | USD 104.9 million |
| Growth rate | 8.1% (CAGR from 2020 to 2027) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Instruments |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.6% of the global blood transfusion diagnostics market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Latin America, Brazil blood transfusion diagnostics market is projected to lead the regional market in terms of revenue in 2027.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 104.9 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Transfusion Diagnostics Market Scope
Blood Transfusion Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Quotient Sciences | View profile | 251-500 | Nottingham, Nottingham, United Kingdom, Europe | https://www.quotientsciences.com/ |
| MedGenome | View profile | 501-1000 | Bangalore, Karnataka, India, Asia | https://diagnostics.medgenome.com |
| Beckman Coulter | View profile | 10001+ | Brea, California, United States, North America | http://www.beckmancoulter.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Mexico blood transfusion diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.45% in 2020. Horizon Databook has segmented the Mexico blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
The Mexico blood transfusion diagnostics market is an emerging market. Obtaining blood for transfusion is a potential challenge in the healthcare sector of developing countries. The supply of contaminated units increases the chances of mortality, morbidity, and the cost for patients.
In Mexico, serological screening is mandatory, however, only selective blood banks regularly perform a Nucleic Acid Test (NAT). According to WHO, Mexico is categorized as an upper-middle-income country with a complex healthcare system. The blood supply is maintained by over 550 blood banks across the country.
The state of Jalisco, Mexico, is the key supplier of Central Blood Bank of the National Western Medical Center and records on an average 68,000 donations per year. From 2021, the Center of the Mexican Social Security Institute has made NAT an internal policy along with serological screening for all blood donations.
Reasons to subscribe to Mexico blood transfusion diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico blood transfusion diagnostics market databook
-
Our clientele includes a mix of blood transfusion diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Mexico blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico blood transfusion diagnostics market size, by end use, 2016-2027 (US$M)
Mexico Blood Transfusion Diagnostics Market Share, 2020 & 2027 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
